CEACAM5 and breast cancer: However, the combination of CEA and CA153 measurement does not possess satisfactory sensitivity in detecting metastasis of breast cancer (29), and the additional measurement of CA125, C-reactive protein (CRP), and other related biomarkers can improve the sensitivity of monitoring tumor progression (30).